SCHEMBL2033355

SCHEMBL2033355

C=CNC1C2CC3CC1CC(C2)C3=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1238943 0.63 HSD11B1 (0.32)
Ethylene SCHEMBL2033353 0.62
SCHEMBL18084060 0.61
Ethylene SCHEMBL1617394 0.57 TSHR (0.37)
SCHEMBL14791313 0.56 TSHR (0.40)
SCHEMBL4721541 0.56 TSHR (0.40)
SCHEMBL71132 0.56 TSHR (0.40)
SCHEMBL10285140 0.56 TSHR (0.40)
Adamantane SCHEMBL9651363 0.56 TSHR (0.40)
SCHEMBL6315184 0.54 TSHR (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581476-B1 AMIDES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2016-11-16 EP disclosed
US-7968601-B2 Treating excess cortisol formation; obesity, cardiovascular disorders, glaucoma, osteoporosis, Alzheimer's Disease; antidiabetic agents JANSSEN PHARMACEUTICA N.V. (BE) 2011-06-28 US disclosed
US-20080096869-A1 ADAMANTYL ACETAMIDES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS LINDERS JOANNES T M 2008-04-24 US disclosed
US-7332524-B2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2008-02-19 US disclosed
US-20060079506-A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors JANSSEN PHARMACEUTICAL N.V. (BE) 2006-04-13 US disclosed
EP-1581476-A2 ADAMANTYL ACETAMIDES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-10-05 EP disclosed
WO-2004056745-A2 ADAMANTYL ACETAMIDES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2004-07-08 WO disclosed
WO-2004056744-A1 ADAMANTYL ACETAMIDES AS HYDROXYSTEROID DEHYDROGENASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2004-07-08 WO disclosed